KAYLA PUTMAN: Open Payments
NPI 1932685237 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 29 payments from 12 companies in 2025. Trend: 2023 $531 · 2024 $782 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Novo Nordisk Inc | 5 | $113 |
| PFIZER INC. | 3 | $80 |
| ABBVIE INC. | 4 | $78 |
| Lilly USA, LLC | 2 | $48 |
| Amgen Inc. | 2 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| Dexcom, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Organogenesis Inc. | 1 | $16 |
Products named: ELIQUIS, AIRSUPRA, QULIPTA, FARXIGA, Ozempic, OTEZLA, ACCRUFER, Wegovy.
Industry payments across NY — which companies pay providers there.
